Ipilimumab Ten Year Anniversary with Sharon Belvin скачать в хорошем качестве

Ipilimumab Ten Year Anniversary with Sharon Belvin

Sharon was one of the first patients to be treated successfully with one of the first FDA approval of checkpoint blockade immunotherapy, ipilimumab. #immunotherapy https://www.cancerresearch.org/ On March 25, 2011, the U.S. Food and Drug Administration announced its approval of a new treatment for advanced melanoma, the deadliest and most difficult-to-treat form of skin cancer. March 25, 2021, marks ten years of this advancement that has helped saved thousands of lives including Sharon Belvin. https://www.cancerresearch.org/news/2... CRI marketing and communications director Brian Brewer and Sharon Belvin discuss the anniversary of ipilimumab, her friendship with Nobel Prize Laureate Dr. James P. Allison, and how this treatment saved her life. CRI ImmunoAdvocate Sharon is passionate about spreading awareness of cancer immunotherapy and sharing her story to inspire hope. https://www.cancerresearch.org/patien... Established in 1953, the Cancer Research Institute (CRI) is a 501(c)(3) nonprofit organization dedicated to harnessing our immune system’s power to control and potentially cure all cancers. Our mission: Save more lives by fueling the discovery and development of powerful immunotherapies for all types of cancer. To accomplish this, we rely on donor support and collaborative partnerships to fund and carry out the most innovative clinical and laboratory research around the world, support the next generation of the field’s leaders, and serve as the trusted source of information on immunotherapy for cancer patients and their caregivers. https://www.cancerresearch.org Cancer Research Institute is a registered 501(c)(3) nonprofit under EIN 13-1837442. Donations are tax-deductible to the fullest extent allowable under the law.